GUARD — Guard Therapeutics International AB (publ) Balance Sheet
0.000.00%
- SEK295.45m
- SEK241.26m
Annual balance sheet for Guard Therapeutics International AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 90 | 189 | 201 | 83.7 | 54.2 |
Net Total Receivables | 0.709 | 0.931 | 0.897 | 0.667 | 0.422 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 91.2 | 190 | 203 | 85.2 | 55.7 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.044 | 0.029 | 0.015 | 0 | 0 |
Other Long Term Assets | |||||
Total Assets | 91.2 | 190 | 203 | 85.2 | 55.7 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 6.5 | 10.9 | 22.7 | 16.6 | 17.7 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 11.5 | 14.7 | 25.2 | 18.5 | 17.8 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 79.7 | 176 | 177 | 66.7 | 38 |
Total Liabilities & Shareholders' Equity | 91.2 | 190 | 203 | 85.2 | 55.7 |
Total Common Shares Outstanding |